Nonspecific intraventricular conduction delay predicts the prognosis of dilated cardiomyopathy

Yong Yuan1,2, Kai Yang1, Qianjun Liu3

  • 1Department of Magnetic Resonance Imaging, Cardiovascular Imaging and Intervention Center, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.

PubMed

Insights

Nonspecific intraventricular conduction delay (NSIVCD) is an unfavorable prognostic marker in dilated cardiomyopathy (DCM) patients. This finding is independent of other key clinical factors, highlighting the importance of NSIVCD in DCM prognosis.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiovascular Imaging

Background:

  • Left bundle branch block (LBBB) is a known adverse prognostic indicator in dilated cardiomyopathy (DCM).
  • Prognostic data for nonspecific intraventricular conduction delay (NSIVCD) in DCM are limited and conflicting.

Purpose of the Study:

  • To evaluate the prognostic significance of NSIVCD in patients with DCM.
  • To compare the outcomes of DCM patients with NSIVCD to those with LBBB, RBBB, and no intraventricular conduction delay (IVCD).

Main Methods:

  • 548 DCM patients undergoing cardiovascular magnetic resonance imaging (CMR) were categorized into four groups: LBBB, RBBB, NSIVCD, and no IVCD.
  • Patients were followed for a median of 58 months for composite endpoints including cardiovascular death, heart transplantation, and malignant arrhythmias.
  • Kaplan-Meier analysis and Cox proportional hazards regression were used to analyze associations between IVCD patterns and outcomes.

Main Results:

  • Patients with NSIVCD and LBBB exhibited higher event rates compared to those without IVCD; RBBB did not show a significant difference.
  • Multivariate Cox regression identified LBBB, NSIVCD, NYHA class, LVEF, LVEDDI, LGE%, and GLS as independent predictors of adverse outcomes in DCM.
  • The average age of the cohort was 46 ± 15 years, with 72.6% males.

Conclusions:

  • Nonspecific intraventricular conduction delay (NSIVCD) is an independent unfavorable prognostic marker in DCM patients.
  • This prognostic value of NSIVCD holds true irrespective of other clinical parameters like LVEDDI, NYHA class, LVEF, LGE%, and GLS.
  • The findings underscore the clinical importance of identifying and assessing NSIVCD in the management of DCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15